| Schedule of Segment Information |
The following table is a summary of segment information for three and nine months ended September 30, 2025 and 2024 (amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended |
|
For the nine months ended |
|
September 30, 2025 |
|
September 30, 2024 |
|
September 30, 2025 |
|
September 30, 2024 |
| Net revenues |
|
|
|
|
|
|
|
| Diagnostic services |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Consumer products |
883 |
|
|
1,416 |
|
|
3,561 |
|
|
5,276 |
|
| Consolidated net revenue |
883 |
|
|
1,416 |
|
|
3,561 |
|
|
5,276 |
|
| Cost of revenue |
|
|
|
|
|
|
|
| Diagnostic services |
7 |
|
|
709 |
|
|
351 |
|
|
1,429 |
|
| Consumer products |
999 |
|
|
492 |
|
|
2,073 |
|
|
3,847 |
|
| Consolidated cost of revenue |
1,006 |
|
|
1,201 |
|
|
2,424 |
|
|
5,276 |
|
| Depreciation and amortization expense |
|
|
|
|
|
|
|
| Diagnostic services |
75 |
|
|
727 |
|
|
614 |
|
|
1,528 |
|
| Consumer products |
623 |
|
|
805 |
|
|
2,235 |
|
|
1,609 |
|
| Total Depreciation and amortization expense |
698 |
|
|
1,532 |
|
|
2,849 |
|
|
3,137 |
|
| Operating and other expenses |
|
|
|
|
|
|
|
| Diagnostic services |
1,163 |
|
|
1,138 |
|
|
2,891 |
|
|
3,162 |
|
| Consumer products |
695 |
|
|
1,160 |
|
|
1,967 |
|
|
2,275 |
|
| Unallocated corporate |
4,317 |
|
|
3,858 |
|
|
8,797 |
|
|
14,739 |
|
| Total operating and other expenses |
6,175 |
|
|
6,156 |
|
|
13,655 |
|
|
20,176 |
|
| Income (loss) from operations, before income taxes |
|
|
|
|
|
|
|
| Diagnostic services |
(1,245) |
|
|
(2,574) |
|
|
(3,856) |
|
|
(6,119) |
|
| Consumer products |
(1,434) |
|
|
(1,041) |
|
|
(2,714) |
|
|
(2,455) |
|
| Unallocated corporate |
(4,317) |
|
|
(3,858) |
|
|
(8,797) |
|
|
(14,739) |
|
| Total loss from operations, before income taxes |
(6,996) |
|
|
(7,473) |
|
|
(15,367) |
|
|
(23,313) |
|
| Income tax (expense) benefit |
157 |
|
|
2,508 |
|
|
(622) |
|
|
7,361 |
|
| Total loss from operations, after income taxes |
(6,839) |
|
|
(4,965) |
|
|
(15,989) |
|
|
(15,952) |
|
| Net loss from continuing operations |
$ |
(6,839) |
|
|
$ |
(4,965) |
|
|
$ |
(15,989) |
|
|
$ |
(15,952) |
|
The following table is a summary of segment information as of September 30, 2025 and December 31, 2024 (amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2025 |
|
December 31, 2024 |
| ASSETS |
|
|
|
| Diagnostic services |
$ |
— |
|
|
$ |
26,069 |
|
| Consumer products |
15,552 |
|
|
19,745 |
|
| Unallocated corporate |
50,150 |
|
|
5,804 |
|
| Assets in discontinued operations |
— |
|
|
11,582 |
|
| Total assets |
$ |
65,702 |
|
|
$ |
63,200 |
|
|